haleon plc glp-1 receptor agonist medications Focus Central To Haleon's North America Turnaround GLP-1 receptor agonists | How
Description
For consumer goods companies, this represents both a challenge and an opportunity

Geiser JS, Heathman MA, Cui X, Martin J, Loghin C, Chien JY, de la Pea A

doi: 10.3390/cells10051236 [DOI] [PMC free article] [PubMed] [Google Scholar] 116.Heni M, Schpfer P, Peter A, et al

Lancet 2019;394:121-30.PubMed 39

Semaglutide, better known by brand names such as Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist drug that has been approved by the U.S

[DOI] [PMC free article] [PubMed] [Google Scholar] 142.Giugliano D., Scappaticcio L., Longo M., Bellastella G., Esposito K